University Alberta_Toxicity Bioassay Health Risk Assessment_xCELLigence_Webinar2014.pdf

-%* %&/ +0 &**0*8%#* %+&.):

$##%#0* *

)*%++ &%,+# %

#+ *"****$%+ &%'+,#)$.&)" $) %) *"****$%+') $

&.)& %$ # *"****$%+ $ #+&/ +0')&3# % +)(,# +0$&% +&) % )')+ ,#++&/ +0 %&+&/ +0 ,+% +0 &**0

,+,))%* % *"****$%+

+)$ %%+*& *"

3% + &%+ *"# #) *!#-(!0' 7 /./*#0()# '/#*-/* *'*"$'.4./ (.

- .0'/$)"!-*( 3+*.0- /*) )1$-*)( )/'#5-?

*0)/1 - ./

) + &%# *"****$%+)&**

% .'%#$+ '%$#$)"'%)) %$$-

1)%+ 3+ &%#/# '/#+-*' (.- 0. 4/#

# ($'B

&*:*'&%*****$%+

#/- /# # '/#*0/*( ./$7 - )/

3+*.0- ' 1 '.B

/'&*,)****$%+

*2(0#*!/# # ($'- + *+' 3+*. /*0-$)"+ -$**!/$( B*2()4+ *+' -

3+*. B

*")+) 1+ &%#/$./# 3/--$.&*!# '/#+-*' (.$)/# 3+*. +*+0'/$*)B

&/ +0*+ %

&$'&%%+*&+A@ * &%

# ($'#-/ -$5/$*)

*3$$/4 ./$)"*3$$/4/#24. -" / ./$)"

*. @ .+*). )3/-+*'/$*)* '$)"

% .'%#%, )-() $ $)76()$)*'-0 ( %$$)')-

) $ + % *"****$%++'* ) + &%#'')& A@;A@

Hazard identification

In vivo animal experiments Endpoint assays (mortality) Epidemiological studies Environmental monitoring

Chemical characterization Toxicity pathway identification Some targeted animal testing Population context

Dose-response assessment

Extrapolation of in vivo animal results to humans

Modeling based on a battery of in vitro assays, systems biology and reverse toxicokinetics

Exposure assessment

Receptors Pathways of exposure Concentration, duration Internal dose

Population data Exposure data (biomonitoring and personal exposure monitoring)

Risk characterization

Quantitative risk assessment models

Biologically relevant health risk assessment

Emerging Technologies

+&*&)##*%#0* * '+ # '0*- . )

/ %>%*+),$%++ &%

%( $($1

) % '#&/ %>

cell 0 cell 0

&% +&) %##) )+ &%&%+/ %>%*+),$%+

$11)"1/#1(1%, %"1/%"16=/755: $$$$

11 ))))))) """""""""1/ ####1

##,#)*'&%**++0+/ %>%*+),$%+

')%)"1/$-"%& %$"-) "# ()'-/7568 ') % ) """" $- """"%&)

$ #&/ +0)&3# %

&/ +0)&3# %)&!+&%'+,#)$.&)"

-6.38

-3.160.05

3.266.48

9.69

EC RATE

8.37

5.70

3.03

0.35

-2.32-4.99

EC Adoptation

-4.40

-3.05

-1.71

-0.36

0.99

2.34

EC Efficiency

PLOT OF EC EFFICIENCY BY EC ADOPTATION BY EC RATE

cluster: CLUSTER ONE CLUSTER TWO

CLUSTER THREE CLUSTER FOUR

CLUSTER FIVE CLUSTER SIX

CLUSTER SEVEN

Mean Graph For CytochalasinB

-2.0 -1.5 -1.0 -0.5 0.0 0.5 1.0 1.5

A549

ARPE

BEAS

HEPG

SKNS

VSMC

Hazard Identification Toxicity Profiling

Cytochalasin B - VSMC

Log10 concentration (uM)

-4 -3 -2 -1 0 1 2

T

o

x

i

c

E

f

f

e

c

t

-150

-100

-50

0

50

100

15024 hr48 hr72 hr96 hr

HTS Cell Panel

Cell Population Kinetics

Dose-Response

Mean Graph

Cluster Analysis Mode of Action

GHS Classification

Reverse Toxicokinetics

In Vivo LD50

Exposure Standards; Health Risk Assessment

Population Exposure

Risk Characterization

Bioinformatics

Chemical Characterization

Chemicals

Metabolites

In Vitro Dose

Mutagenicity Assay

Specialized Assays

LD50 (mmol/kg) vs KC50 (mM)_geomean in 6 Human Cell Lines

log KC50 (mM)_geomean

-10 -8 -6 -4 -2 0 2 4 6

l

o

g

L

D

5

0

R

a

t

(

m

m

o

l

/

k

g

)

-6

-4

-2

0

2

4

logLD50 (mmol/kg) = 0.560xlogKC50 + 0.155

regression line (r = 0.86, r2 = 0.74)RC(12) Prediction Line (r =0.87, r2 = 0.77)Log-5 (RC12) Log +5 (RC12) RC(282) Prediction line (r = 0.67, r2 = 0.45)

&/ +0)&3# %)&!+!+ -*

*0- *!# ($'.-).+*-/)!/

/#24*! 3+*.0- *' 0'-$)$/$/$)" 1 )/

0@ ''0'-*-") '' - .+*). . ''0'- 7 /.$..0 ' .$*).

-")H.4./ (I+/#*'*"4

)$1$0'*-")$.($. .

*+0'/$*) 7 /.*.4./ ( 7 /.

#)$.(*!/$*)

* *!/$*)*3$$/4+/#24

1 -. *0/*( +/#24*0- /**0/*( +/#24

0

.

@

7

/

+

/

#

2

4

#)$.(

*3$

1 *01. Human exposure standards 2. Prediction of in vivo starting doses 3. GHS Classification of chemicals

&/ +0)&3# %)&!+/') $%+#* %

)1$-*)( )/'*)/($))/. ! - ) *(+*0).HI ! - ) # ($'.HI

-$*-$/4# ($'. /#24/$1/*-.@)#$$/*-. +- . )//$1 .*!'..@

3+ -$( )/'# ($'.KUOO

'') 'FT ''$) .

$( @ .+*). 0-1 . *. @ .+*). 0-1 .TO

&/ +0)&3# %)&!+##%#

Cell Line(* Origin Cell Type +Q $1 - +/* ''0'--$)*(@PW 4 *-('- /$)' ''H+$"( )/ ITSW 0)" )*-$)*(H'1 *'-.' ''I@@ -$) 0-*'./*(Q 0)" *-('-*)#$' ''..VS)/ *-('.(''$)/ ./$) $) 4 )' '' )*-$)*(E@ *-/ *-('.(**/#(0.' H*-/IRR *0. (-4* $-*'./

JI0-- )/ '''$) .> +Q

+%#0* *

$?: %)') %+ %

+&&0

$?: %)') %+ %#,*+) %

-6.38

-3.160.05

3.266.48

9.69

EC RATE

8.37

5.70

3.03

0.35

-2.32-4.99

EC Adoptation

-4.40

-3.05

-1.71

-0.36

0.99

2.34

EC Efficiency





CLUSTER SEVEN

-6.38

-3.160.05

3.266.48

9.69

EC RATE

8.37

5.70

3.03

0.35

-2.32-4.99

EC Adoptation

-4.40

-3.05

-1.71

-0.36

0.99

2.34

EC Efficiency





CLUSTER SEVEN

'*/*!-*2/#9$ )44")4/

%)'+&Mean Graph For CytochalasinB

-2.0 -1.5 -1.0 -0.5 0.0 0.5 1.0 1.5

A549

ARPE

BEAS

HEPG

SKNS

VSMC

Mean Graph For CytochalasinD

-0.8 -0.6 -0.4 -0.2 0.0 0.2 0.4 0.6

A549

ARPE

BEAS

HEPG

SKNS

VSMC

Mean Graph For LatrunculinB

-2.0 -1.5 -1.0 -0.5 0.0 0.5 1.0 1.5

A549

ARPE

BEAS

HEPG

SKNS

VSMC

Mean Graph For LatrunculinA

-2.5 -2.0 -1.5 -1.0 -0.5 0.0 0.5 1.0 1.5

A549

ARPE

BEAS

HEPG

SKNS

VSMC

MeMeMeMeMeMeanananananan GGGGGGrarararararaphphphphphphp FFFFFForororororor CytochalasinB

-2.0 -1.5 -1.0 -0.5 0.0 0.5 1.0 1.5

A549

AAARPE

BBEAS

HHHHEPG

SSKNS

VVVVSMC

MeMeMeMeMeMeanananananan GGGGGGrarararararaphphphphphphp FFFFFForororororor CytochalasinD

-0.8 -0.6 -0.4 -0.2 0.0 0.2 0.4 0.6

A549

ARPE

BEAS

HEPG

SKNS

VSMC

Mean Graph For LatrunculinB

-2.0 -1.5 -1.0 -0.5 0.0 0.5 1.0 1.5

A549

ARPE

BEAS

HEPG

SKNS

VSMC

Mean Graph For LatrunculinA

-2.5 -2.0 -1.5 -1.0 -0.5 0.0 0.5 1.0 1.5

A549

AARPE

BBEAS

HHEPG

SSKNS

VVVVSMC

) + &%&+&) *

9 C$;".

9 CC?$;".

9 C?B??$;".

9 B??A7???$;".9 A???C7???$;".

) + &%&+&) * Slope Inter-

cept RC-IC NRU RTCA

Dose Finding

RTCA Definitive

RTCA Definitive

Measure IC50 IC50 KC50 KC50 KC50 Cell Line M

HNK 9 Human

Geomean ACHN HepG2

Chemical 347 51 12 12 12

RC (374) 0.435 0.625 40% 29% 50% 42% 36%

Over-predicted 34% 40% 50% 50% 46%

Under-predicted 26% 31% 0% 8% 9%

Correlation with LD50 values ( r )

0.67

0.68 0.64 0.91(*

0.84 0.69

JIACHN r = 0.91, HepG2 r = 0.64

) + &%&C?LD50 (mmol/kg) vs KC50 (mM)_geomean in 6 Human Cell Lines


-10 -8 -6 -4 -2 0 2 4 6

l

o

g

L

D

5

0

R

a

t

(

m

m

o

l

/

k

g

)

-6

-4

-2

0

2

4


regression line (r = 0.86, r2 = 0.74)RC(12) Prediction Line (r =0.87, r2 = 0.77)Log-5 (RC12) Log +5 (RC12) RC(282) Prediction line (r = 0.67, r2 = 0.45)

L

D

5

0

LDLDLDLDLDLD50 ((((((mmmmmmmm llolololol/k/k/k/k/k/k ))g)g)g)g) vvvvssss KCKCKCKCKCKC50 (((((( MMmMmMmMmM))))))_gegegegeomomomomeaeaeaeannnn iiinininin 666666 HHHHHHumumumumanananan CCCCCC llelelelelllllll LiLiLiLiLiLinenenenessss


-10 -8 -6 -4 -2 0 2 4 6

l l

o

l

o

g g

L L L

m

m

m

m

l

o

l

o

l

/

k

/

k

/

k

)

g

)

g

)

-6

-4

-2

0

2

4


regression line (r = 0.86, r2 = 0.74)RC(12) Prediction Line (r =0.87, r2 = 0.77)Log-5 (RC12) Log +5 (RC12)RC(282) Prediction line (r = 0.67, r2 = 0.45)

L

D

5

0

* % & #*'&%**+&) +#+ *"*

Gene mutation Reporter gene

Gene expression Biomarkers

Molecular initiating

event

Cellular effects

Organelle responses

Receptor binding Ligands

Protein adducts DNA adducts

Ligand binding Enzyme activity Co-activators

Chemical x-actions

Gene activation Protein production

Signaling

Injury Stress

Apoptosis Autophagy Necrosis

Transformation

Cytotoxicity Flow cytometry

Imaging

Biochemical assays s Molecular assays s Cellular assays

)

'

*

!

.

.

4

.

Point of departure

concentration in vitro

Acceptable concentration

in vitro (g/l)

1

-

.

7

/

.

In vivo human exposure standard

(mg/kg/day)

Point of

Systems biology

Reverse toxicokinetics

Toxicity pathway

+),# +0%,$%#+

%)* %',# .)%**%&%)%&,+.+)*,''# *&),$%&%*,$'+ &%

$'+*&%+)&'&% + - + *< %,*+)07) ,#+,)=&%$ )& #%$ #.+)(,# +0

,#+&)0%* /$*)'+ -!*-() ./)-. (+'$)")/ ./$)"- ,0$- ( )/. $-*$'H?*'$

+),# +0%/

#** 3+ &%&&)*

+)&/ +0*+ % ,).+) &+#.+)

Standard Water Toxicity Bioassays

) &3*) #,$ %*% % + &%< )&+&/= $%&'#,*'#+0,),*$&)+# +0 '% $% $$& # 1+ &%%)')&,+ &%

(5*)@$* "-*

-#&'$%+&:*+)&/ +0 &**0 Develop and demonstrate the utility of a human cell-

based / %> screening assay to assess toxicity of various source waters

Introduce a toxicity index to evaluate degrees of toxicity in various types of water *$/11/)"1/$'&*" ) %$TCRC Curve

Dose-response

Curve Toxicity Heat

Map Water Toxicity

Index Bar

S1 S2 S3 S4 S5 S6 S7 S8 S9 S10 S11 S120

1

2

3

4

5

6

7

8

Water SamplesT

o

x

i

c

i

t

y

I

n

d

e

x

Concentration

W

a

t

e

r

S

a

m

p

l

e

s

Colormap for Toxicity Index in HepG2

80% 60% 40% 30% 20% 10%

S1

S2

S3

S4

S5

S6

S7

S8

S9

S10

S11

S12

1

2

3

4

5

6

7

8

9

Sorry,thedatawillbesharedonceitispublished.

Sorry, the data will be shared once it is published.Sorry,thedatawillbesharedonceitispublished.

Sorry the data will be shared once it is publishedSorry,thedatawillbesharedonceitispublished.

Speed (High-throughput screening) Early indication of hazard Human relevance Multiple cell types (Cell panel) Exposure relevance Mixtures Quick evaluation of environmental incidents Cost-effective

%3+*&++/ %> &**0

+)+)&%+$ %%+*&)"

)&++ %,)+)) +

).&

)#,+ &%%#+ *"* ))$%0 2)%++0'*& )'#,+%+*)&$

. )%&*&,)* $&*+ $'&)+%+++)+**%')+ #*

++-%&,%+&&%+) ,++&) &-*,#)%)*' )+&)0 **

/#()0

),# +0#+%/

,)+1)+ #%,##,#)'&%**

*$ )"1/$"-()/755=/688/;982;9=

C?#,*&&,)0'*&)+ ,#+* %::@##*

*$ )"1/$"-()/755=/688/;982;9=

Urban dustDiesel exhaust

&1)&,*A9C%%&')+ #*

0+&+&/ +0)&3#*&,)+1 )&')+ #*

&/ +0)&3#%C?&)+ ,#+* %::@##*

')%)"1/$-"%& %$"-) "# ()'-/7568 '''' )))))))) %%%% )))))))) """""""""1/ $$$$----"""""""%"%"%"%&&&))))))))

Quartz particles (Q66)Urban dust (SRM1649a)

Concentrated air particles (CAPs)

/ %> ))+ ,#+

%&+&/ +0 )&. %+)) %+,$%#+

%*+0) *"*&%%&$+) #* %&$+) #*-,% (,+&/ ')&')+ *

,*&+ )'0* #')&')+ *

&/ +0)&3##*)+. +%%% A

')%)"1/$"-) # )/7568/=84>5

&/ +0)&3#&:@##*)+. +%)+ #*

')%)"1/$-"%& %$"-) "# ()'-/7568

,+% +0 &**0

,++ &%*)%* %+*(,%&%,#&+ *. + %##,*0$,+%*

+)+0&),+% +0*+ % &%* )+ &%* $ #*+),+,)%#**7')&')+ * + *$7)+ - +07 & #+ - +0 &,+*&/'&*,)7 &- # # +07+)++ **,

$+&* +) #+*+*&)%$,++ &%*

)&&&&%'+,++ &% &**0

''"-*2/#&$) /$. . '$) )/#- .#*' ..4'$-/$*)

+-*0$$'$/4 *(+-$.*)*!$*..4. $11/)"1$" %$"#/7567/651655

&%#,* &%*,++ &%**0 -$&%*+)++')&&&&%'+&%&-#

&**0&)+++ &%&$,++##* *$+&')&- *'&.),#+&. + )

+)&,',+&)%&+&/ +0+*+ % -,*7&)+3)*++ $7##)&.+" %+ ,)-*

&)+(,%+ 3+ &%&$,+%+##* )*,#+*&+ %. ++) %#&*)$%+

. ++&*&+&%-%+ &%#%&+&/ +0**0 ,)+)'++ &%%-# + &%&+**0 *)(, )

&)*)% %+,#$,+% %- )&%$%+#$ #*

,+,))%* %&/ +0*+ %% *"****$%+

%+ 3+ &%&+&/ +0'+.0*%$&&+ &%&$ #*

%+)')++ &%%-#,+ &%&+ & # %&)$+ &%)&$#+) *"****$%+')*'+ -

-#&'$%+&$% *+ ##0:*') + -$*& & #)*'&%*

$)%&%.)*&''# + &% %',# #+) *"****$%+

,+,))%* %%&0

&%+ %, $')&-$%+& :+)&,',+*)% %+%& *

-#&'$%+&+&/ +0:*3#$&% +&) % %*+),$%+*:*%* + -7'&)+#7*+#- *:&) )(,# +0%.+)+&/ +0****$%+

,#+ '#/ %& $'%))0*. +&+)##:*+%& *

"%&.#$%+*

#&)+&)*8

'&%*&)*8

#)&4*0A

0 ./$*).B

Documents

University Alberta_Toxicity Bioassay Health Risk Assessment_xCELLigence_Webinar2014.pdf